Statins and neuroprotection

The beneficial effect of β-hydroxy-β-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) in primary prevention of coronary artery disease in those with hypercholesterolaemia and in secondary prevention in those with established coronary vascular disease are now well known. A growing b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Expert opinion on investigational drugs 2001-10, Vol.10 (10), p.1847-1853
Hauptverfasser:	Sheehy, Niall, Vaughan, Carl J, Delanty, Norman
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Dementia - drug therapy Dementia - pathology endothelium HMG-CoA reductase inhibitors Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use neuroprotection Neuroprotective Agents - therapeutic use nitric oxide statins stroke Stroke - drug therapy Stroke - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!